These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11686632)

  • 1. Nanoporous biocapsules for the encapsulation of insulinoma cells: biotransport and biocompatibility considerations.
    Leoni L; Desai TA
    IEEE Trans Biomed Eng; 2001 Nov; 48(11):1335-41. PubMed ID: 11686632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micromachined interfaces: new approaches in cell immunoisolation and biomolecular separation.
    Desai TA; Hansford DJ; Ferrari M
    Biomol Eng; 2000 Oct; 17(1):23-36. PubMed ID: 11042474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microfabrication technology for pancreatic cell encapsulation.
    Desai TA
    Expert Opin Biol Ther; 2002 Aug; 2(6):633-46. PubMed ID: 12171507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microfabricated biocapsules provide short-term immunoisolation of insulinoma xenografts.
    Desai TA; Chu WH; Rasi G; Sinibaldi-Vallebona P; Guarino E; Ferrari M
    Biomed Microdevices; 1999; 1(2):131-8. PubMed ID: 16281113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microfabricated immunoisolating biocapsules.
    Desai TA; Chu WH; Tu JK; Beattie GM; Hayek A; Ferrari M
    Biotechnol Bioeng; 1998 Jan; 57(1):118-20. PubMed ID: 10099185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoporous microsystems for islet cell replacement.
    Desai TA; West T; Cohen M; Boiarski T; Rampersaud A
    Adv Drug Deliv Rev; 2004 Sep; 56(11):1661-73. PubMed ID: 15350295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoporous alumina capsules for cellular macroencapsulation: transport and biocompatibility.
    La Flamme KE; Mor G; Gong D; La Tempa T; Fusaro VA; Grimes CA; Desai TA
    Diabetes Technol Ther; 2005 Oct; 7(5):684-94. PubMed ID: 16241869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An encapsulation system for the immunoisolation of pancreatic islets.
    Wang T; Lacík I; Brissová M; Anilkumar AV; Prokop A; Hunkeler D; Green R; Shahrokhi K; Powers AC
    Nat Biotechnol; 1997 Apr; 15(4):358-62. PubMed ID: 9094138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of insulinoma cells as therapy in insulin-dependent diabetes mellitus].
    Schnedl WJ
    Wien Klin Wochenschr; 1999 Jun; 111(11):428-33. PubMed ID: 10420493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid pancreatic tissue substitute consisting of recombinant insulin-secreting cells and glucose-responsive material.
    Cheng SY; Gross J; Sambanis A
    Biotechnol Bioeng; 2004 Sep; 87(7):863-73. PubMed ID: 15334413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of calcium channels of a glucose-responsive rat insulinoma.
    Hoenig M; Russo LL; Ferguson DC
    Am J Physiol; 1989 Apr; 256(4 Pt 1):E488-93. PubMed ID: 2539735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of alginate encapsulation on NIT-1 insulinoma cells: viability, growth and insulin secretion.
    Bertolotti A; Borgogna M; Facoetti A; Marsich E; Nano R
    In Vivo; 2009; 23(6):929-35. PubMed ID: 20023235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine insulinoma cell line with normal glucose-regulated insulin secretion.
    Efrat S; Leiser M; Surana M; Tal M; Fusco-Demane D; Fleischer N
    Diabetes; 1993 Jun; 42(6):901-7. PubMed ID: 8495813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo biocompatibility evaluation of cellulose macrocapsules for islet immunoisolation: Implications of low molecular weight cut-off.
    Risbud MV; Bhargava S; Bhonde RR
    J Biomed Mater Res A; 2003 Jul; 66(1):86-92. PubMed ID: 12833434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced stimulus-secretion coupling in polyamine-depleted rat insulinoma cells. An effect involving increased cytoplasmic Ca2+, inositol phosphate generation, and phorbol ester sensitivity.
    Sjöholm A; Arkhammar P; Welsh N; Bokvist K; Rorsman P; Hallberg A; Nilsson T; Welsh M; Berggren PO
    J Clin Invest; 1993 Oct; 92(4):1910-7. PubMed ID: 8408643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of somatostatin receptors in RINm5F insulinoma cells.
    Sullivan SJ; Schonbrunn A
    Endocrinology; 1988 Mar; 122(3):1137-45. PubMed ID: 2893729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Embedded-culture of pancreatic beta-cells derived from transgenic mouse insulinoma as a potential source for xenotransplantation using a diffusion chamber.
    Ohgawara H; Miyazaki J; Karibe S; Tashiro F; Akaike T; Hashimoto Y
    Cell Transplant; 1995; 4(3):307-13. PubMed ID: 7640870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells.
    Merglen A; Theander S; Rubi B; Chaffard G; Wollheim CB; Maechler P
    Endocrinology; 2004 Feb; 145(2):667-78. PubMed ID: 14592952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards the development of a bioartificial pancreas: immunoisolation and NMR monitoring of mouse insulinomas.
    Sambanis A; Papas KK; Flanders PC; Long RC; Kang H; Constantinidis I
    Cytotechnology; 1994; 15(1-3):351-63. PubMed ID: 7765950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin secretion in vivo and in vitro from transplantable NEDH rat insulinoma and derived clonal RINm5F cell line.
    Flatt PR; DeSilva M; Swanston-Flatt SK; Marks V
    Diabetes Res; 1987 Oct; 6(2):85-90. PubMed ID: 2827934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.